Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video)
"Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project…

What happens next will shock you…"
Click here to see what happened.

ADVM Insider Trading (Adverum Biotechnologies)

Insider Ownership Percentage: 12.40%
Insider Buying (Last 12 Months): $413,154.00
Insider Selling (Last 12 Months): $2,704,939.84

Adverum Biotechnologies Insider Trading History Chart

Adverum Biotechnologies Share Price & Price History

$9.08
▼ -0.63 (-6.49%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
100X Gains On Tap as Under-the-Radar Green-Tech Stock Soars
Searching for the next 1,000% stock winner? Look no further than key Green-Techs that are driving the EV, Solar & 5G booms. Silver is the #1 element in the Green Energy Revolution & we’ve found the top silver gem – undiscovered at 10-cents per share – that’s fueling the path to a carbon-free world.
Get the details here...
pixel

Adverum Biotechnologies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/24/2021Laurent FischerCEOBuy10,000$9.88$98,800.0026,292  
2/9/2021Leone D PattersonCFOSell12,533$14.10$176,715.3098,017  
1/15/2021Laurent FischerCEOBuy8,600$11.53$99,158.0016,292  
1/15/2021Patrick MachadoDirectorBuy10,000$11.52$115,200.0078,182  
8/17/2020Peter SoparkarinsiderBuy7,692$13.00$99,996.007,692  
7/20/2020Mehdi GasmiDirectorSell5,000$17.60$88,000.00279,442  
6/22/2020Mehdi GasmiDirectorSell23,605$25.06$591,541.30298,047  
6/18/2020Mehdi GasmiDirectorSell11,395$25.01$284,988.95274,710  
6/16/2020Leone D PattersonPresidentSell13,171$24.68$325,060.28110,488  
6/15/2020Mehdi GasmiDirectorSell10,000$21.86$218,600.00284,442  
5/20/2020Mehdi GasmiDirectorSell1,401$20.01$28,034.01275,843  
5/18/2020Mehdi GasmiDirectorSell5,000$18.17$90,850.00  
5/6/2020Leone D. PattersonCEOSell20,000$20.02$400,400.00  
5/6/2020Mehdi GasmiDirectorSell25,000$20.03$500,750.00  
3/20/2020Leone D PattersonCEOSell39,526$10.17$401,979.42162,955  
3/17/2020Leone D PattersonCEOSell474$10.02$4,749.48138,531  
2/14/2020James Paul ScopaDirectorBuy10,000$15.79$157,900.00  
2/12/2020Mehdi GasmiDirectorSell10,000$15.07$150,700.00321,418  
5/6/2019James Paul ScopaDirectorBuy20,000$6.71$134,200.00  
See Full Table

SEC Filings (Institutional Ownership Changes) for Adverum Biotechnologies (NASDAQ:ADVM)

97.41% of Adverum Biotechnologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adverum Biotechnologies Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
3/12/2021DekaBank Deutsche Girozentrale32,500$0.38M0.0%N/A0.033%
3/8/2021Dimensional Fund Advisors LP1,709,739$18.54M0.0%-8.7%1.748%
3/2/2021Norges Bank63,988$0.69M0.0%N/A0.066%
3/1/2021UBS Asset Management Americas Inc.579,809$6.29M0.0%-31.0%0.595%
2/25/2021Dimensional Fund Advisors LP1,709,739$18.54M0.0%-8.7%1.754%
2/24/2021Virtu Financial LLC20,665$0.22M0.0%-36.5%0.021%
2/23/2021Principal Financial Group Inc.39,799$0.43M0.0%+46.0%0.041%
2/19/2021JPMorgan Chase & Co.568,010$6.16M0.0%+50.0%0.583%
2/18/2021Truist Financial Corp38,934$0.42M0.0%+19.8%0.040%
2/17/2021Twinbeech Capital LP29,390$0.32M0.1%-19.8%0.030%
2/16/2021Orbimed Advisors LLC5,501,144$59.63M0.5%+20.0%5.643%
2/16/2021Squarepoint Ops LLC25,819$0.28M0.0%-71.9%0.026%
2/16/2021HighVista Strategies LLC54,525$0.59M0.4%+52.3%0.056%
2/16/2021Morgan Stanley653,884$7.09M0.0%+1,135.6%0.671%
2/16/2021Paloma Partners Management Co14,083$0.15M0.0%N/A0.014%
2/16/2021Nuveen Asset Management LLC397,228$4.31M0.0%+0.3%0.408%
2/16/2021Price T Rowe Associates Inc. MD1,657,433$17.97M0.0%+57.1%1.700%
2/16/2021Engineers Gate Manager LP33,810$0.37M0.0%-53.2%0.035%
2/16/2021ExodusPoint Capital Management LP12,112$0.13M0.0%N/A0.012%
2/16/2021HarbourVest Partners LLC134,154$1.45M0.6%N/A0.138%
2/16/2021Charles Schwab Investment Management Inc.593,298$6.43M0.0%+3.6%0.609%
2/12/2021Raymond James Financial Services Advisors Inc.31,020$0.34M0.0%N/A0.032%
2/12/2021The Manufacturers Life Insurance Company53,538$0.58M0.0%+8.1%0.055%
2/12/2021Credit Suisse AG92,492$1M0.0%-43.1%0.095%
2/12/2021CHI Advisors LLC59,209$0.64M0.2%-15.4%0.061%
2/12/2021Virtus ETF Advisers LLC21,057$0.23M0.1%+45.7%0.022%
2/11/2021Trexquant Investment LP11,876$0.13M0.0%N/A0.012%
2/11/2021Northern Trust Corp1,051,533$11.40M0.0%-0.9%1.079%
2/11/2021Barclays PLC294,782$3.19M0.0%-25.6%0.302%
2/11/2021Citigroup Inc.35,537$0.39M0.0%-84.0%0.036%
2/11/2021Artal Group S.A.2,500,000$27.10M0.6%+38.9%2.565%
2/11/2021Dynamic Technology Lab Private Ltd26,989$0.29M0.0%N/A0.028%
2/10/2021Rhumbline Advisers118,241$1.28M0.0%+7.8%0.121%
2/10/2021HighTower Advisors LLC20,750$0.23M0.0%+3.9%0.021%
2/9/2021Wells Fargo & Company MN78,149$0.85M0.0%+72.8%0.080%
2/9/2021ClariVest Asset Management LLC22,609$0.25M0.0%-57.7%0.023%
2/9/2021Bank of New York Mellon Corp337,940$3.66M0.0%+1.8%0.347%
2/9/2021Trustees of Princeton University74,530$0.81M1.2%N/A0.076%
2/9/2021Mitsubishi UFJ Kokusai Asset Management Co. Ltd.19,781$0.21M0.0%+105.9%0.020%
2/9/2021ProShare Advisors LLC34,757$0.38M0.0%+33.8%0.036%
2/8/2021New York State Common Retirement Fund78,700$0.85M0.0%+17.5%0.081%
2/8/2021Russell Investments Group Ltd.80,227$0.87M0.0%-31.9%0.082%
2/5/2021Massachusetts Institute of Technology134,154$1.45M1.6%N/A0.138%
2/5/2021BlackRock Inc.7,042,768$76.34M0.0%+3.5%7.225%
2/5/2021Aperio Group LLC15,780$0.17M0.0%+25.2%0.016%
2/5/2021Swiss National Bank129,100$1.40M0.0%-7.6%0.132%
2/5/2021Tiff Advisory Services Inc.19,573$0.24M0.1%N/A0.020%
2/5/2021SG Americas Securities LLC15,102$0.16M0.0%-84.6%0.015%
2/4/2021Los Angeles Capital Management LLC39,832$0.43M0.0%-3.5%0.041%
2/4/2021State of Wisconsin Investment Board121,800$1.32M0.0%+4.4%0.125%
2/1/2021Victory Capital Management Inc.112,387$1.22M0.0%-13.0%0.115%
2/1/2021Assenagon Asset Management S.A.22,198$0.24M0.0%-91.9%0.023%
1/28/2021Arizona State Retirement System16,557$0.18M0.0%-10.9%0.017%
1/28/2021Dupont Capital Management Corp24,240$0.26M0.0%+89.0%0.025%
1/27/2021Chicago Partners Investment Group LLC14,216$0.19M0.0%N/A0.015%
1/25/2021Nisa Investment Advisors LLC4,730$51K0.0%+39.9%0.005%
1/22/2021Candriam Luxembourg S.C.A.298,492$3.24M0.0%-1.7%0.306%
1/21/2021Hershey Trust Co.29,812$0.32M0.0%N/A0.031%
1/20/2021Pacer Advisors Inc.5,346$58K0.0%+40.4%0.005%
1/13/2021Hamilton Lane Advisors LLC54,624$0.59M0.2%N/A0.056%
12/30/2020Deerfield Management Company L.P. Series C2,404,439$24.77M0.5%+188.3%2.467%
12/11/2020Virtu Financial LLC32,527$0.34M0.1%+20.8%0.033%
11/17/2020Twinbeech Capital LP36,659$0.38M0.1%N/A0.038%
11/17/2020Voloridge Investment Management LLC54,364$0.56M0.0%+419.7%0.056%
11/17/2020California State Teachers Retirement System131,526$1.36M0.0%+19.5%0.135%
11/17/2020Schonfeld Strategic Advisors LLC142,295$1.47M0.0%+154.1%0.146%
11/16/2020Point72 Hong Kong Ltd4,094$42K0.0%N/A0.004%
11/16/2020Cubist Systematic Strategies LLC136,966$1.41M0.0%N/A0.141%
11/16/2020JS Capital Management LLC11,400$0.12M0.0%N/A0.012%
11/16/2020AQR Capital Management LLC65,878$0.68M0.0%-26.2%0.068%
11/16/2020OLD Mission Capital LLC15,900$0.16M0.0%N/A0.016%
11/16/2020Squarepoint Ops LLC92,037$0.95M0.0%N/A0.094%
11/16/2020Engineers Gate Manager LP72,311$0.75M0.0%N/A0.074%
11/13/2020Morgan Stanley52,919$0.54M0.0%-10.8%0.054%
11/13/2020Truist Financial Corp32,500$0.34M0.0%+109.7%0.033%
11/13/2020Allianz Asset Management GmbH270,091$2.78M0.0%+12.7%0.277%
11/13/2020ProShare Advisors LLC25,973$0.27M0.0%+14.1%0.027%
11/13/2020Charles Schwab Investment Management Inc.572,682$5.90M0.0%+26.6%0.587%
11/13/2020UBS Asset Management Americas Inc.840,504$8.66M0.0%+9.2%0.862%
11/13/2020Virtus ETF Advisers LLC14,457$0.15M0.1%-12.0%0.015%
11/12/2020JPMorgan Chase & Co.378,598$3.96M0.0%+28.9%0.388%
11/12/2020Arrowstreet Capital Limited Partnership14,400$0.15M0.0%N/A0.015%
11/12/2020Federated Hermes Inc.83,617$0.86M0.0%-63.3%0.086%
11/12/2020WS Management Lllp858,000$8.84M1.0%+22.0%0.880%
11/11/2020Thrivent Financial for Lutherans89,668$0.92M0.0%N/A0.092%
11/10/2020State Street Corp5,627,389$57.96M0.0%+61.9%6.977%
11/10/2020TD Asset Management Inc.43,501$0.45M0.0%-40.8%0.054%
11/9/2020SG Americas Securities LLC98,254$1.01M0.0%+743.6%0.122%
11/9/2020Caas Capital Management LP250,077$2.58M0.1%N/A0.310%
11/9/2020The Manufacturers Life Insurance Company49,530$0.51M0.0%+13.7%0.061%
11/9/2020ClariVest Asset Management LLC53,496$0.55M0.0%-4.3%0.066%
11/9/2020Victory Capital Management Inc.129,171$1.33M0.0%-1.3%0.160%
11/9/2020Quantitative Systematic Strategies LLC40,340$0.42M0.1%+36.1%0.050%
11/6/2020BlackRock Inc.6,802,150$70.06M0.0%+15.1%8.433%
11/6/2020GSA Capital Partners LLP11,661$0.12M0.0%N/A0.014%
11/6/2020Aigen Investment Management LP30,240$0.31M0.0%N/A0.037%
11/5/2020California Public Employees Retirement System200,806$2.07M0.0%+21.2%0.249%
11/5/2020Wells Fargo & Company MN45,215$0.47M0.0%-7.5%0.056%
11/4/2020American International Group Inc.51,950$0.54M0.0%+16.3%0.064%
11/4/2020Mackay Shields LLC79,900$0.82M0.0%+110.3%0.099%
Data available starting January 2016

See Full Table
Adverum Biotechnologies logo
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal diseases, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.
Read More

Today's Range

Now: $9.08
$8.98
$9.60

50 Day Range

MA: $11.05
$9.26
$13.33

52 Week Range

Now: $9.08
$8.98
$26.98

Volume

1,239,242 shs

Average Volume

843,060 shs

Market Capitalization

$887.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.72

Who are the company insiders with the largest holdings of Adverum Biotechnologies?

Adverum Biotechnologies' top insider shareholders include:
  1. Mehdi Gasmi (Director)
  2. Leone D Patterson (CEO)
  3. Leone D Patterson (President)
  4. Leone D Patterson (CFO)
  5. Patrick Machado (Director)
  6. Laurent Fischer (CEO)
  7. Peter Soparkar (Insider)
  8. James Paul Scopa (Director)
  9. Leone D Patterson (CEO)
Emergency Briefing: “The Great Reset”
By May 28th, Americans could be faced with a difficult choice: Accept a "Great Reset" and risk losing the American way of life... or stand up and fight back to save what's left of the American dream. Jeff Brown, a member of a D.C.-based advocacy group, explains what every American must do before May 28th to preserve his assets and thrive.
Click here to see this emergency briefing before i